Paper36928207
Dihydroartemisinin-induced ferroptosis in acute myeloid leukemia: links to iron metabolism and metallothionein.
Grignano E and 12 others. Cell Death Discov, 2023. Cited by 50 papers, by iCite.
Cite this record
ConductScience Library. Dihydroartemisinin-induced ferroptosis in acute myeloid leukemia: links to iron metabolism and metallothionein. Papers, record 36928207. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36928207
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Dihydroartemisinin-induced ferroptosis in acute myeloid leukemia: links to iron metabolism and metallothionein.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References37
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32431605 | Iron Promotes Dihydroartemisinin Cytotoxicity via ROS Production and Blockade of Autophagic Flux via Lysosomal Damage in Osteosarcoma. | Front Pharmacol | 2020 | https://conductscience.org/library/papers/32431605 | PubMed |
| 2 | 26186940 | Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition. | Blood | 2015 | https://conductscience.org/library/papers/26186940 | PubMed |
| 3 | 24439385 | Regulation of ferroptotic cancer cell death by GPX4. | Cell | 2014 | https://conductscience.org/library/papers/24439385 | PubMed |
| 4 | 21991581 | Ferritin and metallothionein: dangerous liaisons. | Chem Commun (Camb) | 2011 | https://conductscience.org/library/papers/21991581 | PubMed |
| 5 | 23502468 | The role of metallothionein in oxidative stress. | Int J Mol Sci | 2013 | https://conductscience.org/library/papers/23502468 | PubMed |
| 6 | 24844246 | Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis. | Elife | 2014 | https://conductscience.org/library/papers/24844246 | PubMed |
| 7 | 19177017 | Single-vector inducible lentiviral RNAi system for oncology target validation. | Cell Cycle | 2009 | https://conductscience.org/library/papers/19177017 | PubMed |
| 8 | 27141961 | Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. | Nucleic Acids Res | 2016 | https://conductscience.org/library/papers/27141961 | PubMed |
| 9 | 27477901 | Dihydroartemisinin (DHA) induces ferroptosis and causes cell cycle arrest in head and neck carcinoma cells. | Cancer Lett | 2016 | https://conductscience.org/library/papers/27477901 | PubMed |
| 10 | 34262021 | DHA exhibits synergistic therapeutic efficacy with cisplatin to induce ferroptosis in pancreatic ductal adenocarcinoma via modulation of iron metabolism. | Cell Death Dis | 2021 | https://conductscience.org/library/papers/34262021 | PubMed |
| 11 | 31740834 | The chemical basis of ferroptosis. | Nat Chem Biol | 2019 | https://conductscience.org/library/papers/31740834 | PubMed |
| 12 | 23586463 | Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. | BMC Bioinformatics | 2013 | https://conductscience.org/library/papers/23586463 | PubMed |
| 13 | 25516281 | Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. | Genome Biol | 2014 | https://conductscience.org/library/papers/25516281 | PubMed |
| 14 | 26407947 | Artemisinin derivatives induce iron-dependent cell death (ferroptosis) in tumor cells. | Phytomedicine | 2015 | https://conductscience.org/library/papers/26407947 | PubMed |
| 15 | 21907397 | Artemisinin: discovery from the Chinese herbal garden. | Cell | 2011 | https://conductscience.org/library/papers/21907397 | PubMed |
| 16 | 12869643 | Molecular modes of action of artesunate in tumor cell lines. | Mol Pharmacol | 2003 | https://conductscience.org/library/papers/12869643 | PubMed |
| 17 | 33363031 | Acute Myeloid Leukemia: From Biology to Clinical Practices Through Development and Pre-Clinical Therapeutics. | Front Oncol | 2020 | https://conductscience.org/library/papers/33363031 | PubMed |
| 18 | 11764006 | Selective toxicity of dihydroartemisinin and holotransferrin toward human breast cancer cells. | Life Sci | 2001 | https://conductscience.org/library/papers/11764006 | PubMed |
| 19 | 31114026 | Artemisinin compounds sensitize cancer cells to ferroptosis by regulating iron homeostasis. | Cell Death Differ | 2020 | https://conductscience.org/library/papers/31114026 | PubMed |
| 20 | 27015352 | Metallothionein-1G facilitates sorafenib resistance through inhibition of ferroptosis. | Hepatology | 2016 | https://conductscience.org/library/papers/27015352 | PubMed |
Cited by38
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 50 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42776828 | Metallothionein Isoforms in Acute Myeloid Leukemia: Roles in Survival, Differentiation, and Stress Adaptation. | Hematol Rep | 2026 | https://conductscience.org/library/papers/42776828 | PubMed |
| 42694667 | DHA Targets RAB1B to Mediate the Driving Force Transmission of Copper Ion Vesicular Endocytosis Under Copper Overload for Promoting Cuproptosis and Ferroptosis in Hepatic Stellate Cells. | Int J Biol Sci | 2026 | https://conductscience.org/library/papers/42694667 | PubMed |
| 42524207 | Arteannuin B Induces Ferroptosis in Colorectal Cancer Cells via GDF15/HMGCS1/GPX4 Axis. | J Cancer | 2026 | https://conductscience.org/library/papers/42524207 | PubMed |
| 42431858 | Acid ceramidase modulates the lipid profile and exacerbates sensitivity to ferroptosis in WI-38 replicative senescent cells. | Cell Death Dis | 2026 | https://conductscience.org/library/papers/42431858 | PubMed |
| 42196362 | Bufalin Suppresses Pancreatic Ductal Adenocarcinoma Through ER Stress-Ferroptosis Crosstalk Associated with IP3R-Linked Ca2+ Dysregulation and ATF3/SLC7A11 Regulation. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42196362 | PubMed |
| 42053642 | Repurposing artesunate in acute myeloid leukemia: a pharmacokinetic rationale derived from antimalarial data. | Cancer Chemother Pharmacol | 2026 | https://conductscience.org/library/papers/42053642 | PubMed |
| 41935320 | Therapeutic profiling of dihydroartemisinin using in vitro and in vivo models reveals anti-glioma potential. | Cancer Cell Int | 2026 | https://conductscience.org/library/papers/41935320 | PubMed |
| 41833023 | The Role of Artemisinin and its Derivatives in Cancer Therapy via Ferroptosis: A Systematic Review of In Vitro, In Vivo, and In Silico Studies. | Anticancer Agents Med Chem | 2026 | https://conductscience.org/library/papers/41833023 | PubMed |
| 41741409 | The protective up-regulation of metallothionein-2A in intervertebral disc degeneration inhibits nucleus pulposus cell ferroptosis through activation of the PI3K/AKT/mTOR pathway. | Cell Death Discov | 2026 | https://conductscience.org/library/papers/41741409 | PubMed |
| 41640441 | NCOA4 and ferritinophagy in hematological malignancies: a double-edged regulator of iron metabolism and cell fate. | Front Oncol | 2025 | https://conductscience.org/library/papers/41640441 | PubMed |
| 41531728 | HMOX1 drives dihydroartemisinin-sensitized ferroptosis antagonized by mitochondrial fusion. | iScience | 2026 | https://conductscience.org/library/papers/41531728 | PubMed |
| 41518462 | Macrophage ferroptosis in hematologic malignancies: emerging mechanisms and therapeutic implications. | Apoptosis | 2026 | https://conductscience.org/library/papers/41518462 | PubMed |
| 41462004 | Ferroptosis in hematological malignancies: molecular mechanisms and therapeutic potential. | Cell Oncol (Dordr) | 2025 | https://conductscience.org/library/papers/41462004 | PubMed |
| 41356368 | Acid ceramidase modulates the lipid profile and exacerbates sensitivity to ferroptosis in senescent cells. | Res Sq | 2025 | https://conductscience.org/library/papers/41356368 | PubMed |
| 41117998 | Ferroptosis in AML: nanoparticles, biomarkers, and immune rewiring for therapeutic breakthroughs. | Discov Oncol | 2025 | https://conductscience.org/library/papers/41117998 | PubMed |
| 40892295 | Synergistic Ferroptosis-Immunotherapy Nanoplatforms: Multidimensional Engineering for Tumor Microenvironment Remodeling and Therapeutic Optimization. | Nanomicro Lett | 2025 | https://conductscience.org/library/papers/40892295 | PubMed |
| 40822033 | Ferroptosis as a therapeutic target in glioblastoma: Mechanisms and emerging strategies. | Mol Ther Nucleic Acids | 2025 | https://conductscience.org/library/papers/40822033 | PubMed |
| 40490812 | Natural anti-cancer products: insights from herbal medicine. | Chin Med | 2025 | https://conductscience.org/library/papers/40490812 | PubMed |
| 40488837 | Ferroptosis: a novel therapeutic warrior in the battle against leukemia. | Apoptosis | 2025 | https://conductscience.org/library/papers/40488837 | PubMed |
| 40241743 | BMAL1-depletion remodels ceramide metabolism to regulate ferroptosis and sorafenib chemosensitivity in acute myeloid leukemia. | iScience | 2025 | https://conductscience.org/library/papers/40241743 | PubMed |
Genes39
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36928207
GET https://conductscience.org/api/papers/v1/36928207/references?page=2